Evidence map›Paper›PMID 34360880›Full record

ArticleInternational journal of molecular sciences2021

An Evaluation of Human Induced Pluripotent Stem Cells to Test for Cardiac Developmental Toxicity.

Lauren Michelle Walker, Nicole R L Sparks, Veronica Puig-Sanvicens, Beatriz Rodrigues, Nicole I Zur Nieden

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Advances in Cytotoxicity Testing: From In Vitro Assays to In Silico Models.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. hiPSC-Derived Cells as Models for Drug Discovery 2.0.International journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lauren Michelle WalkerStem Cell Center and Department of Molecular, Cell & Systems Biology, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, USA.
Nicole R L SparksStem Cell Center and Department of Molecular, Cell & Systems Biology, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, USA.ORCID 0000-0001-6176-7895
Veronica Puig-SanvicensStem Cell Center and Department of Molecular, Cell & Systems Biology, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, USA.
Beatriz RodriguesStem Cell Center and Department of Molecular, Cell & Systems Biology, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, USA.
Nicole I Zur NiedenStem Cell Center and Department of Molecular, Cell & Systems Biology, College of Natural and Agricultural Sciences, University of California Riverside, Riverside, CA 92521, USA.ORCID 0000-0003-4063-5070

Funding

Center for Alternatives to Animal Testing, Johns Hopkins Bloomberg School of Public Health 2013-11R1Center for Alternatives to Animal Testing, Johns Hopkins Bloomberg School of Public Health 2014-14R2EPA EPA-STAR-83950201
6 · The paper itself

Abstract

To prevent congenital defects arising from maternal exposure, safety regulations require pre-market developmental toxicity screens for industrial chemicals and pharmaceuticals. Traditional embryotoxicity approaches depend heavily on the use of low-throughput animal models which may not adequately predict human risk. The validated embryonic stem cell test (EST) developed in murine embryonic stem cells addressed the former problem over 15 years ago. Here, we present a proof-of-concept study to address the latter challenge by updating all three endpoints of the classic mouse EST with endpoints derived from human induced pluripotent stem cells (hiPSCs) and human fibroblasts. Exposure of hiPSCs to selected test chemicals inhibited differentiation at lower concentrations than observed in the mouse EST. The hiPSC-EST also discerned adverse developmental outcomes driven by novel environmental toxicants. Evaluation of the early cardiac gene

Indexed as

AnimalsCell DifferentiationCells, CulturedCell SurvivalCongenital AbnormalitiesEmbryonic DevelopmentFibroblastsFluorouracilHumansInduced Pluripotent Stem CellsMiceMouse Embryonic Stem CellsMyocytes, CardiacPenicillin GT-Box Domain ProteinsTeratogensFluorouracilPenicillin GT-Box Domain ProteinsT-box transcription factor 5TeratogensTretinoincardiomyocytesembryonic stem cell testembryotoxicity screeninduced pluripotent stem cellstobacco smoke solution

Identifiers

PMID34360880
PMCPMC8347148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.